Breast density C, officially called “heterogeneously dense,” means your breasts have many areas of dense glandular and fibrous tissue mixed with some areas of fatty tissue. It’s the second-highest of four density categories, and about 4 out of every 10 women fall into this group. The classification comes from your mammogram and appears in your results using a system called BI-RADS, developed by the American College of Radiology.
How the Four Density Categories Work
Every mammogram assigns your breast tissue one of four density levels, labeled A through D. Category A is almost entirely fatty tissue. Category B has scattered areas of dense tissue but is still mostly fatty. Category C, your result, has many areas of dense tissue with some fatty areas mixed in. Category D is extremely dense, with very little fatty tissue visible at all.
Categories C and D are both considered “dense.” Categories A and B are considered “not dense.” This distinction matters because it determines what notification you receive after your mammogram and what screening steps might come next.
Why Density Makes Mammograms Harder to Read
On a mammogram, fatty tissue appears dark while dense tissue appears white. The problem is that tumors and calcifications also appear white. When you have heterogeneously dense breasts, those white areas of normal tissue can overlap with and hide abnormal growths. This is called the masking effect.
Standard 2D mammography misses roughly 25% of cancers in women with heterogeneously dense breasts. That’s a meaningful gap. For comparison, the miss rate climbs to about 40% in women with extremely dense tissue (Category D), so Category C is better but still poses a real challenge for detection.
Does Category C Increase Cancer Risk?
Yes, and this is separate from the masking problem. Dense breast tissue is itself an independent risk factor for breast cancer. Women with heterogeneously dense breasts have about 2.8 times the risk of developing breast cancer compared to women with entirely fatty breasts (Category A), and roughly 1.5 times the risk compared to women with scattered density (Category B).
That said, having dense breasts doesn’t mean you will get breast cancer. It’s one risk factor among many, including family history, age, genetics, and lifestyle. But it’s significant enough that federal regulations now require mammography facilities to tell you about it directly.
What Your Mammogram Report Must Tell You
As of September 2024, the FDA requires every mammography facility in the U.S. to include a breast density assessment in your report and to send you a plain-language summary. Because Category C is classified as dense, your notification will include language stating that dense tissue makes it harder to find cancer on a mammogram, that it raises the risk of developing breast cancer, and that other imaging tests may help find cancers that mammography misses.
If you received your mammogram before this rule took effect, your facility may or may not have included density information. Many states already had their own notification laws, but the federal rule now makes it universal.
Screening Options Beyond Standard Mammography
A standard 2D mammogram is still the foundation of breast cancer screening, but for Category C density, there are additional tools worth discussing with your provider.
3D mammography (tomosynthesis) is considered the most appropriate next step for women with heterogeneously dense breasts at average risk. It takes multiple thin images of the breast from different angles, which can help separate overlapping layers of tissue. It detects an additional 1 to 2 cancers per thousand women screened compared to 2D alone. However, a cancer hidden by dense tissue on a 2D image can still be hidden on 3D unless it’s at least partially surrounded by fatty tissue.
Breast ultrasound uses sound waves instead of X-rays and can find cancers that mammograms miss in dense tissue. The American College of Radiology considers it a reasonable option for women with Category C density, particularly those who can’t undergo MRI. The tradeoff: ultrasound has a higher rate of false positives, meaning it’s more likely to flag something that turns out to be benign and leads to an unnecessary biopsy or follow-up.
Breast MRI with contrast is the most sensitive screening tool available. For women at average risk with heterogeneously dense breasts, it falls into the “may be appropriate” category. For women at intermediate or higher risk who also have dense tissue, MRI becomes a stronger recommendation. It’s more expensive and time-consuming than other options, but it catches cancers the other methods miss. If you’re already getting MRI screening, adding ultrasound provides no extra benefit.
What You Can Do With This Information
Your density category isn’t something you can change through diet, exercise, or medication. It’s largely determined by genetics, though density does tend to decrease somewhat with age and can be affected by hormonal factors like menopause or hormone therapy.
The most useful thing you can do is combine your density result with your other risk factors to figure out the right screening plan. If Category C is your only elevated risk factor, 3D mammography is a solid baseline, with ultrasound as a possible addition. If you have other risk factors on top of dense tissue, such as a strong family history or known genetic mutations, more intensive screening with MRI may be warranted. Your overall risk profile, not density alone, determines the best approach.
Density can also fluctuate between mammograms. You might be classified as C on one screening and B on the next, especially around menopause. If your category changes, your screening recommendations may change with it.